Cancer Immunology, Malmö
41 – 50 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Expression of PD-L1 and PD-1 in chemoradiotherapy-Naïve esophageal and gastric adenocarcinoma : Relationship with mismatch repair status and survival
- Contribution to journal › Article
-
Mark
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
- Contribution to journal › Article
-
Mark
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer : a comparative study of transurethral resection and cystectomy specimens
- Contribution to journal › Article
-
Mark
Establishment of Melanoma Tumor Xenograft Using Single Cell Line Suspension and Co-injection of Patient-Derived T Cells in Immune-Deficient NSG Mice
- Contribution to journal › Article
-
Mark
Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
- Contribution to journal › Article
- 2018
-
Mark
Docetaxel promotes the generation of anti-tumorigenic human macrophages
- Contribution to journal › Article
-
Mark
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
- Contribution to journal › Article
- 2017
-
Mark
On the origin of myeloid-derived suppressor cells
- Contribution to journal › Scientific review
-
Mark
The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
- Contribution to journal › Article
-
Mark
The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype
- Contribution to journal › Article
